Carregant...
The safety and efficacy of novel agents targeting factor XI and XII in early phase human trials.
Although anticoagulation without hemorrhage is a primary aim, this vision has remained as yet out of reach. Even despite the superior safety profile of the direct oral anticoagulants, hemorrhage remains a major risk of anticoagulation. Selective inhibition of the contact pathway of coagulation, spec...
Guardat en:
| Publicat a: | Semin Thromb Hemost |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6657806/ https://ncbi.nlm.nih.gov/pubmed/31216587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0039-1692439 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|